83 related articles for article (PubMed ID: 30593761)
21. Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP.
Wang YK; Shen L; Jiao X; Zhang XT
World J Gastroenterol; 2018 Jan; 24(2):266-273. PubMed ID: 29375212
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
23. Preoperative serum C-reactive protein and gastric cancer; clinical-pathological correlation and prognostic significance.
Chang CC; Sun CF; Pai HJ; Wang WK; Hsieh CC; Kuo LM; Wang CS
Chang Gung Med J; 2010; 33(3):301-12. PubMed ID: 20584508
[TBL] [Abstract][Full Text] [Related]
24. Serum soluble vascular adhesion protein-1 is a valuable prognostic marker in gastric cancer.
Yasuda H; Toiyama Y; Ohi M; Mohri Y; Miki C; Kusunoki M
J Surg Oncol; 2011 Jun; 103(7):695-9. PubMed ID: 21308684
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the Clinical Significance of Serum Carcinoembryonic Antigen in Patients with Resectable Gastric Adenocarcinoma.
Dang Y; Ouyang X; Wang K; Zhang F; Huang Q
Arch Med Res; 2016 Apr; 47(3):196-9. PubMed ID: 27387021
[TBL] [Abstract][Full Text] [Related]
26. Perioperative Serum Carcinoembryonic Antigen Levels Predict Recurrence and Survival of Patients with Pathological T2-4 Gastric Cancer Treated with Curative Gastrectomy.
Uda H; Kanda M; Tanaka C; Kobayashi D; Inaoka K; Tanaka Y; Hayashi M; Iwata N; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
Dig Surg; 2018; 35(1):55-63. PubMed ID: 28441659
[TBL] [Abstract][Full Text] [Related]
27. Detection of preoperative serum anti-p53 antibodies in gastric cancer.
Nakajima K; Suzuki T; Shimada H; Hayashi H; Takeda A; Ochiai T
Tumour Biol; 1999; 20(3):147-52. PubMed ID: 10213922
[TBL] [Abstract][Full Text] [Related]
28. Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer.
Chan AO; Chu KM; Lam SK; Wong BC; Kwok KF; Law S; Ko S; Hui WM; Yueng YH; Wong J
J Clin Oncol; 2003 Jun; 21(12):2288-93. PubMed ID: 12805328
[TBL] [Abstract][Full Text] [Related]
29. Correlation of Caveolin-1 Expression with Prognosis in Patients with Gastric Cancer after Gastrectomy.
Seker M; Aydin D; Bilici A; Yavuzer D; Ozgun MG; Ozcelik M; Aydin O; Aliustaoglu M
Oncol Res Treat; 2017; 40(4):185-190. PubMed ID: 28365694
[TBL] [Abstract][Full Text] [Related]
30. Titration of serum p53 antibodies in patients with gastric cancer: a single-institute study of 40 patients.
Shimizu K; Ueda Y; Yamagishi H
Gastric Cancer; 2005; 8(4):214-9. PubMed ID: 16328595
[TBL] [Abstract][Full Text] [Related]
31. Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer.
Xia HH; Yang Y; Chu KM; Gu Q; Zhang YY; He H; Wong WM; Leung SY; Yuen ST; Yuen MF; Chan AO; Wong BC
Cancer; 2009 Dec; 115(23):5441-9. PubMed ID: 19685530
[TBL] [Abstract][Full Text] [Related]
32. Serum neopterin as a prognostic indicator in patients with gastric carcinoma.
Unal B; Kocer B; Altun B; Surmeli S; Aksaray S; Balci M; Ozlu B; Cengiz O
J Invest Surg; 2009; 22(6):419-25. PubMed ID: 20001811
[TBL] [Abstract][Full Text] [Related]
33. [Preliminary results regarding vascular endothelial growth factor (VEGF-A) levels in the serum of gastric cancer patients].
Hălmaciu I; Gurzu S; Dobreanu M; Suciu BA; Brînzaniuc K
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):446-51. PubMed ID: 23077935
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
[TBL] [Abstract][Full Text] [Related]
35. [The prognosis and clinicopathological characteristics of 70 gastric cancer patients with elevated serum AFP].
Wang YK; Shen L; Zhang XT
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):514-517. PubMed ID: 28728297
[No Abstract] [Full Text] [Related]
36. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
Wang CS; Wu TL; Tsao KC; Sun CF
Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
38. Relationship between serum soluble vascular adhesion protein-1 level and gastric cancer prognosis.
Kaplan MA; Kucukoner M; Inal A; Urakci Z; Evliyaoglu O; Firat U; Kaya M; Isikdogan A
Oncol Res Treat; 2014; 37(6):340-4. PubMed ID: 24903765
[TBL] [Abstract][Full Text] [Related]
39. SUVmax of 18F-FDG PET/CT correlates to expression of major chemotherapy-related tumor markers and serum tumor markers in gastric adenocarcinoma patients.
Bai L; Guo CH; Zhao Y; Gao JG; Li M; Shen C; Guo YM; Duan XY
Oncol Rep; 2017 Jun; 37(6):3433-3440. PubMed ID: 28498457
[TBL] [Abstract][Full Text] [Related]
40. [Correlation of caveolin-1 expression with clinicopathologic features and prognosis in patients with lung adenocarcinoma].
Wang Y; Liu B; Xu Y; Zhang J; Xia Q; Yu B; Zhang R; Shi S; Lu Z; Zhou X
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):251-5. PubMed ID: 24915816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]